Detalles de la búsqueda
1.
Safety, immunogenicity and efficacy of the self-amplifying mRNA ARCT-154 COVID-19 vaccine: pooled phase 1, 2, 3a and 3b randomized, controlled trials.
Nat Commun;
15(1): 4081, 2024 May 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38744844
2.
A phase I/II randomized, double-blinded, placebo-controlled trial of a self-amplifying Covid-19 mRNA vaccine.
NPJ Vaccines;
7(1): 161, 2022 Dec 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36513697
3.
Immune gene expression analysis indicates the potential of a self-amplifying Covid-19 mRNA vaccine.
NPJ Vaccines;
7(1): 154, 2022 Nov 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36443317
4.
Assessment of the safety, tolerability and kinetics of the immune response to A/H1N1v vaccine formulations with and without adjuvant in healthy pediatric subjects from 3 through 17 years of age.
Hum Vaccin;
7(1): 58-66, 2011 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21285531
5.
Cumulative clinical experience with MF59-adjuvanted trivalent seasonal influenza vaccine in young children and adults 65 years of age and older.
Int J Infect Dis;
85S: S10-S17, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-30904674
6.
Cumulative clinical experience with MF59-adjuvanted trivalent seasonal influenza vaccine in young children.
Int J Infect Dis;
85S: S26-S38, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31096055
7.
Responses to 2009 H1N1 vaccine in children 3 to 17 years of age.
N Engl J Med;
362(4): 370-2, 2010 Jan 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-20042746
8.
Immunogenicity and safety of a cell culture-based quadrivalent influenza vaccine in adults: A Phase III, double-blind, multicenter, randomized, non-inferiority study.
Hum Vaccin Immunother;
12(9): 2278-88, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27322354
9.
Non-inferiority of mammalian cell-derived quadrivalent subunit influenza virus vaccines compared to trivalent subunit influenza virus vaccines in healthy children: a phase III randomized, multicenter, double-blind clinical trial.
Int J Infect Dis;
41: 65-72, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26585940
10.
A dose-ranging study in older adults to compare the safety and immunogenicity profiles of MF59®-adjuvanted and non-adjuvanted seasonal influenza vaccines following intradermal and intramuscular administration.
Hum Vaccin Immunother;
10(6): 1701-10, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24732325
11.
Superior immunogenicity of seasonal influenza vaccines containing full dose of MF59 (®) adjuvant: results from a dose-finding clinical trial in older adults.
Hum Vaccin Immunother;
8(2): 216-27, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22426371
12.
Trivalent and quadrivalent MF59(®)-adjuvanted influenza vaccine in young children: a dose- and schedule-finding study.
Vaccine;
29(47): 8696-704, 2011 Nov 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-21906647
13.
MF59-adjuvanted versus non-adjuvanted influenza vaccines: integrated analysis from a large safety database.
Vaccine;
27(49): 6959-65, 2009 Nov 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-19751689
14.
Efficacy and safety of oxybutynin in children with detrusor hyperreflexia secondary to neurogenic bladder dysfunction.
J Urol;
173(1): 221-5, 2005 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-15592080
Resultados
1 -
14
de 14
1
Próxima >
>>